789
Views
37
CrossRef citations to date
0
Altmetric
Report

Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis

, , , , , , , , , , , , , , & show all
Pages 600-613 | Received 07 May 2012, Accepted 22 Jun 2012, Published online: 06 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Ulrich Brinkmann & Roland E. Kontermann. (2017) The making of bispecific antibodies. mAbs 9:2, pages 182-212.
Read now
Andrea Chiricozzi, Rosita Saraceno, Lucia Novelli, Monika Fida, Francesco Caso, Raffaele Scarpa, Luisa Costa, Roberto Perricone, Marco Romanelli, Sergio Chimenti & Maria Sole Chimenti. (2016) Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015). Expert Opinion on Therapeutic Patents 26:7, pages 757-766.
Read now
Feifan Yu, Lindvi Gudmundsdotter, Anastassja Akal, Elin Gunneriusson, Fredrik Frejd & Per-Åke Nygren. (2014) An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo. mAbs 6:6, pages 1598-1607.
Read now
Chris Spahr, Stone D-H Shi & Hsieng S Lu. (2014) O-Glycosylation of glycine-serine linkers in recombinant Fc-fusion proteins. mAbs 6:4, pages 904-914.
Read now
Lukas Bossaller & Achim Rothe. (2013) Monoclonal antibody treatments for rheumatoid arthritis. Expert Opinion on Biological Therapy 13:9, pages 1257-1272.
Read now
Mitchell Ho, Ivor Royston & Alain Beck. (2012) 2nd PEGS Annual Symposium on Antibodies for Cancer Therapy. mAbs 4:5, pages 562-570.
Read now

Articles from other publishers (31)

Fatemeh Khodadust, Aiarpi Ezdoglian, Maarten M. Steinz, Judy R. van Beijnum, Gerben J. C. Zwezerijnen, Gerrit Jansen, Sander W. Tas & Conny J. van der Laken. (2022) Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis. International Journal of Molecular Sciences 23:13, pages 7071.
Crossref
Xing Li, Lianjie Bai, Yinghui Zhang, Ying Wang, Yang Shi & Huilin Liu. (2021) Novel GLP-1/anti-apolipoprotein B bifunctional fusion protein alleviates diabetes and diabetic complications in combination with low-intensity ultrasound. Life Sciences 278, pages 119549.
Crossref
Xiaotian Zhong & Aaron M. D’Antona. (2021) Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics. Antibodies 10:2, pages 13.
Crossref
Jia-Min Wang, Wang-Dong Xu, Zhi-Chao Yuan, Qian Wu, Jie Zhou & An-Fang Huang. (2021) Serum levels and gene polymorphisms of angiopoietin 2 in systemic lupus erythematosus patients. Scientific Reports 11:1.
Crossref
Elba Mauriz. 2021. Surface Plasmon Resonance in Bioanalysis. Surface Plasmon Resonance in Bioanalysis 339 401 .
Qi Zhao. (2020) Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date. BioDrugs 34:2, pages 111-119.
Crossref
Pawel A Kabala, Beatriz Malvar-Fernández, Ana P Lopes, Tiago Carvalheiro, Sarita A Y Hartgring, Man Wai Tang, Carmen Conde, Dominique L Baeten, Matthew Sleeman, Paul P Tak, Jane Connor, Timothy R Radstake, Kris A Reedquist & Samuel García. (2020) Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients. Rheumatology 59:2, pages 426-438.
Crossref
Gonçalo Boleto, Lukshe Kanagaratnam, Moustapha Dramé & Jean-Hugues Salmon. (2019) Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 49:1, pages 35-42.
Crossref
Matthieu Chodorge, Anthony J. Celeste, Joseph Grimsby, Anish Konkar, Pia Davidsson, David Fairman, Lesley Jenkinson, Jacqueline Naylor, Nicholas White, Jonathan C. Seaman, Karen Dickson, Benjamin Kemp, Jennifer Spooner, Emmanuel Rossy, David C. Hornigold, James L. Trevaskis, Nicholas J. Bond, Timothy B. London, Andrew Buchanan, Tristan Vaughan, Cristina M. Rondinone & Jane K. Osbourn. (2018) Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment. Scientific Reports 8:1.
Crossref
Emilie Branche, William Weihao Tang, Karla M. Viramontes, Matthew Perry Young, Nicholas Sheets, Yunichel Joo, Anh-Viet T. Nguyen & Sujan Shresta. (2018) Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection. Antiviral Research 158, pages 1-7.
Crossref
Sophie Steeland, Claude Libert & Roosmarijn E. Vandenbroucke. (2018) A New Venue of TNF Targeting. International Journal of Molecular Sciences 19:5, pages 1442.
Crossref
Petra Verdino, Shane Atwell & Stephen J Demarest. (2018) Emerging trends in bispecific antibody and scaffold protein therapeutics. Current Opinion in Chemical Engineering 19, pages 107-123.
Crossref
Tianshu Xu, Tianlei Ying, Lili Wang, Xiaohua Douglas Zhang, Ying Wang, Lishan Kang, Tao Huang, Liang Cheng, Liping Wang & Qi Zhao. (2017) A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A. Oncotarget 8:47, pages 81860-81872.
Crossref
Pratiek Matkar, Ramya Ariyagunarajah, Howard Leong-Poi & Krishna Singh. (2017) Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis. Biomolecules 7:4, pages 74.
Crossref
Pipsa Saharinen, Lauri Eklund & Kari Alitalo. (2017) Therapeutic targeting of the angiopoietin–TIE pathway. Nature Reviews Drug Discovery 16:9, pages 635-661.
Crossref
A. Al-Soudi, M.H. Kaaij & S.W. Tas. (2017) Endothelial cells: From innocent bystanders to active participants in immune responses. Autoimmunity Reviews 16:9, pages 951-962.
Crossref
Agathe Leblond, Yannick Allanore & Jérôme Avouac. (2017) Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmunity Reviews 16:6, pages 594-601.
Crossref
Fredrik Y Frejd & Kyu-Tae Kim. (2017) Affibody molecules as engineered protein drugs. Experimental & Molecular Medicine 49:3, pages e306-e306.
Crossref
Chrissta X. Maracle, Paulina Kucharzewska, Boy Helder, Corine van der Horst, Pedro Correa de Sampaio, Ae-Ri Noort, Katinka van Zoest, Arjan W. Griffioen, Henric Olsson & Sander W. Tas. (2017) Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis. Rheumatology 56:2, pages 294-302.
Crossref
Alain C. Tissot & Ulrich Brinkmann. 2017. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases 75 97 .
E. Mauriz, M.C. García-Fernández & L.M. Lechuga. (2016) Towards the design of universal immunosurfaces for SPR-based assays: A review. TrAC Trends in Analytical Chemistry 79, pages 191-198.
Crossref
Youngkyun Kim, Hyoju Yi, Hyerin Jung, Yeri Alice Rim, Narae Park, Juryun Kim, Seung Min Jung, Sung-Hwan Park, Young Woo Park & Ji Hyeon Ju. (2016) A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis. Scientific Reports 6:1.
Crossref
Sander W. Tas, Chrissta X. Maracle, Emese Balogh & Zoltán Szekanecz. (2015) Targeting of proangiogenic signalling pathways in chronic inflammation. Nature Reviews Rheumatology 12:2, pages 111-122.
Crossref
Mathieu Ferrari, Shimobi C. Onuoha & Costantino Pitzalis. (2016) Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis. Drug Discovery Today 21:1, pages 172-179.
Crossref
Catherine T.K. Le, Grace Laidlaw, Christopher A. Morehouse, Brian Naiman, Philip Brohawn, Tomas Mustelin, Jane R. Connor & Donald M. McDonald. (2015) Synergistic Actions of Blocking Angiopoietin-2 and Tumor Necrosis Factor-α in Suppressing Remodeling of Blood Vessels and Lymphatics in Airway Inflammation. The American Journal of Pathology 185:11, pages 2949-2968.
Crossref
Cristina Martínez-Fernández de la Cámara, Alberto M. Hernández-Pinto, Lorena Olivares-González, Carmen Cuevas-Martín, María Sánchez-Aragó, David Hervás, David Salom, José M. Cuezva, Enrique J. de la Rosa, José M Millán & Regina Rodrigo. (2015) Adalimumab Reduces Photoreceptor Cell Death in A Mouse Model of Retinal Degeneration. Scientific Reports 5:1.
Crossref
Alexander Scholz, Karl H. Plate & Yvonne Reiss. (2015) Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Annals of the New York Academy of Sciences 1347:1, pages 45-51.
Crossref
Mathieu Ferrari, Shimobi C. Onuoha & Costantino Pitzalis. (2015) Trojan horses and guided missiles: targeted therapies in the war on arthritis. Nature Reviews Rheumatology 11:6, pages 328-337.
Crossref
Chrissta X. Maracle & Sander W. Tas. (2014) Inhibitors of angiogenesis: Ready for prime time?. Best Practice & Research Clinical Rheumatology 28:4, pages 637-649.
Crossref
A. Campanati, G. Moroncini, G. Ganzetti, K.N. Pozniak, G. Goteri, A. Giuliano, E. Martina, G. Liberati, F. Ricotti, A. Gabrielli & A. Offidani. (2013) Adalimumab Modulates Angiogenesis in Psoriatic Skin. European Journal of Inflammation 11:2, pages 489-498.
Crossref
David Chandler & Anthony Bewley. (2013) Biologics in Dermatology. Pharmaceuticals 6:4, pages 557-578.
Crossref